Univac is a preclinical-stage biotechnology start-up that develops NK-cells directed vaccines and immune therapies. By targeting unconventional antigens and activating Natural Killer cells, Univac has discovered a new transformative approach that allows development of universally protective vaccines that prevent or cure a broad range of acute viral infections and immune-mediated (allergies and immune inflammatory diseases) or tumour diseases. Univac vaccines have the potential to meet medical needs for which vaccines or treatments do not exist or, where available, are very expensive.
Company Details
- Employees
- 39
- Founded
- 2013
- Address
- Gaston Geenslaan 1, Leuven,3010,belgium
- Phone
- 65 6854 3333
- ma****@****.com.sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- universal-vaccines.com
- Keywords
- Vaccines and NK Cells.
- HQ
- Leuven
Univac Questions
Univac's helpline number is 65 6854 3333
Univac's website is universal-vaccines.com
Univac's LinkedIn profile is https://be.linkedin.com/company/univac
Univac has
39 employees.
View email and phone details for 39
employees at Univac.
Univac's industry is
Biotechnology Research
Univac's support email address is marketing@univac.com.sg
Univac's categories are Biotechnology Research
Univac's founding year is 2013
